FDA makes changes for device and emergency use authorizations

07/30/2013 | Clinica

The FDA will provide a single submission number for investigational device exemptions and emergency use authorizations beginning Aug. 18, which will allow the agency to track multiple studies and milestones more efficiently and will streamline the entire process. Subsequent submissions to an IDE or EUA will be assigned to the appropriate study and will be classified as supplements, reports or amendments. Under the new system, companies should ensure that they include only one submission reason per IDE submission

View Full Article in:

Clinica

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY